Traditional software stocks delivered a powerful risk-on signal on August 27, 2026, even as the cryptocurrency market had no direct exposure to the moves.
Veeva Systems surged 20% to $294.54, its best daily percentage gain on record, after fiscal Q2 2027 revenue rose 18% year over year to $928 million, beating the $905 million consensus. Adjusted EPS of $2.35 beat the $2.22 estimate. Subscription revenue grew 16% to $766.8 million, and non-GAAP operating margins held above 44%. Management raised full-year FY2027 revenue guidance to $3.68-$3.69 billion and lifted adjusted EPS guidance to $9.21 from $9.05. Eli Lilly and Biogen joined Vault CRM, bringing top-20 biopharma clients on the platform to 12. CEO Peter Gassner said Vault CRM had its best quarter ever and Veeva Falcon accelerated rapidly, adding that AI is opening up the next big chapter for Veeva and life sciences.
Salesforce also jumped more than 20% to about $252.05 after fiscal Q2 2027 revenue reached $11.35 billion, up 10.8% year over year. Adjusted EPS came in at $5.90, far above the roughly $3.27 expected. Adjusted operating margin was 34.1%, and Salesforce raised its full-year revenue outlook to $46.1-$46.4 billion. The company forecast Q3 revenue of $11.42-$11.50 billion and adjusted EPS of $3.42-$3.44. Salesforce also expanded its AI partnership with Anthropic, connecting Claude with Salesforce products; Salesforce holds an investment stake in Anthropic.
Broader equity markets strengthened, with the Nasdaq gaining 1.1% and the S&P 500 adding 0.5%. Nvidia earnings earlier in the week reignited appetite for technology and software stocks. Nearly 20 analyst firms raised Veeva price targets, including Barclays to $315 and Guggenheim to $310. Morgan Stanley flagged Veeva's November 5 investor day as a referendum on its AI strategy. For crypto markets, the earnings moves were neutral, with no direct coin-specific catalysts in the reports.
